If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

INBX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.80%

Insider Buying (Last 12 Months): $39,999,990.00

Insider Selling (Last 12 Months): $9,215,542.05

Inhibrx Insider Trading History Chart

Inhibrx Share Price & Price History

^$20.53

▼ -1.21 (-5.57%)

As of 03/22/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Inhibrx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2023	Brendan P. Eckelman	Insider	Sell	28,750	$24.73	$710,987.50	2,086,803
1/23/2023	Jon Faiz Kayyem	Director	Sell	9,500	$25.26	$239,970.00	3,224,301
1/23/2023	Mark Lappe	CEO	Sell	21,665	$25.36	$549,424.40	2,490,587
1/3/2023	Brendan P. Eckelman	Insider	Sell	32,895	$23.77	$781,914.15	2,122,658
12/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$27.02	$256,690.00	3,233,801
12/19/2022	Mark Lappe	CEO	Sell	26,000	$25.56	$664,560.00	2,512,252
12/6/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.22	$1,088,800.00	2,155,553
11/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$29.89	$283,955.00	3,243,301
11/1/2022	Brendan P. Eckelman	Insider	Sell	40,000	$33.51	$1,340,400.00	2,195,553
10/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$30.13	$286,235.00	3,252,801
10/17/2022	Mark Lappe	CEO	Sell	26,000	$29.59	$769,340.00	2,564,252
10/7/2022	Global Investors Lp Viking	Major Shareholder	Buy	1,333,333	$30.00	$39,999,990.00	2,427,307
10/4/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.82	$1,112,800.00	2,235,553
8/2/2022	Brendan P. Eckelman	Insider	Sell	24,500	$17.70	$433,650.00	2,491,053
7/7/2022	Brendan P. Eckelman	Insider	Sell	40,000	$17.17	$686,800.00	2,515,553
4/5/2022	Brendan P. Eckelman	Insider	Sell	400	$25.04	$10,016.00
3/24/2021	Brendan P. Eckelman	Insider	Sell	17,000	$19.02	$323,340.00
2/16/2021	Brendan P. Eckelman	Insider	Sell	17,000	$25.90	$440,300.00	234,709
8/26/2020	Global Investors Lp Viking	Major Shareholder	Buy	180,219	$18.92	$3,409,743.48
8/24/2020	Global Investors Lp Viking	Major Shareholder	Buy	46,161	$19.43	$896,908.23

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Inhibrx (NASDAQ:INBX)

72.79% of Inhibrx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inhibrx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2023	Voya Investment Management LLC	12,557	$0.31M	0.0%	+6.7%	0.029%
2/15/2023	MetLife Investment Management LLC	17,746	$0.44M	0.0%	+3.0%	0.041%
2/15/2023	State of Wisconsin Investment Board	21,922	$0.54M	0.0%	-6.2%	0.050%
2/15/2023	Soleus Capital Management L.P.	478,302	$11.79M	1.7%	+31.4%	1.098%
2/15/2023	Squarepoint Ops LLC	15,299	$0.38M	0.0%	+5.0%	0.035%
2/15/2023	Morgan Stanley	257,018	$6.33M	0.0%	+59.6%	0.590%
2/15/2023	E Fund Management Co. Ltd.	10,315	$0.25M	0.0%	N/A	0.024%
2/15/2023	EAM Global Investors LLC	44,524	$1.10M	0.3%	N/A	0.102%
2/15/2023	EAM Investors LLC	30,240	$0.75M	0.2%	N/A	0.069%
2/15/2023	Endurant Capital Management LP	13,485	$0.33M	0.1%	N/A	0.031%
2/15/2023	ArrowMark Colorado Holdings LLC	1,139,337	$28.07M	0.3%	-14.9%	2.616%
2/15/2023	Bamco Inc. NY	70,000	$1.73M	0.0%	N/A	0.161%
2/14/2023	Point72 Asset Management L.P.	752,500	$18.54M	0.1%	+64.6%	1.728%
2/14/2023	Vident Investment Advisory LLC	26,068	$0.64M	0.0%	N/A	0.060%
2/14/2023	RA Capital Management L.P.	3,853,867	$94.96M	1.9%	N/A	8.849%
2/14/2023	Marshall Wace LLP	31,480	$0.78M	0.0%	N/A	0.072%
2/14/2023	Two Sigma Investments LP	246,001	$6.06M	0.0%	+50.5%	0.565%
2/14/2023	Pura Vida Investments LLC	93,575	$2.31M	0.1%	N/A	0.215%
2/13/2023	Platinum Investment Management Ltd.	160,127	$3.95M	0.2%	+9.5%	0.368%
2/13/2023	Gyon Technologies Capital Management LP	44,074	$1.09M	0.4%	N/A	0.101%
2/13/2023	Charles Schwab Investment Management Inc.	247,922	$6.11M	0.0%	+11.9%	0.569%
2/13/2023	Deutsche Bank AG	17,877	$0.44M	0.0%	+28.7%	0.041%
2/13/2023	Wells Fargo & Company MN	7,460	$0.18M	0.0%	-15.4%	0.017%
2/13/2023	Barclays PLC	106,603	$2.56M	0.0%	+22.4%	0.245%
2/13/2023	Credit Suisse AG	19,116	$0.47M	0.0%	-4.1%	0.044%
2/13/2023	Geode Capital Management LLC	575,697	$14.19M	0.0%	+15.9%	1.322%
2/13/2023	GSA Capital Partners LLP	19,068	$0.47M	0.1%	N/A	0.044%
2/13/2023	JPMorgan Chase & Co.	32,271	$0.80M	0.0%	+12.0%	0.074%
2/13/2023	M&T Bank Corp	28,965	$2.18M	0.0%	+7.0%	0.067%
2/10/2023	Bank of America Corp DE	146,467	$3.61M	0.0%	+14.5%	0.336%
2/10/2023	American International Group Inc.	15,411	$0.38M	0.0%	+11.2%	0.035%
2/10/2023	Amalgamated Bank	5,452	$0.13M	0.0%	+18.1%	0.013%
2/10/2023	New York Life Investment Management LLC	25,458	$0.63M	0.0%	+12.7%	0.058%
2/10/2023	Schroder Investment Management Group	375,075	$9.24M	0.0%	-19.2%	0.861%
2/10/2023	Victory Capital Management Inc.	43,560	$1.07M	0.0%	-43.3%	0.100%
2/10/2023	Advisor Group Holdings Inc.	8,365	$0.21M	0.0%	-5.4%	0.019%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	14,627	$0.36M	0.0%	+16.6%	0.034%
2/9/2023	Victory Capital Management Inc.	43,560	$1.07M	0.0%	-43.3%	0.100%
2/9/2023	Principal Financial Group Inc.	9,950	$0.25M	0.0%	N/A	0.023%
2/9/2023	Citigroup Inc.	86,513	$2.13M	0.0%	-28.8%	0.199%
2/9/2023	HighTower Advisors LLC	132,708	$3.27M	0.0%	+0.6%	0.305%
2/8/2023	UBS Group AG	89,247	$2.20M	0.0%	+401.5%	0.205%
2/8/2023	Swiss National Bank	56,600	$1.40M	0.0%	+2.0%	0.130%
2/8/2023	Russell Investments Group Ltd.	319,545	$7.87M	0.0%	-6.2%	0.734%
2/7/2023	State Board of Administration of Florida Retirement System	9,578	$0.24M	0.0%	-10.4%	0.022%
2/6/2023	Los Angeles Capital Management LLC	41,399	$1.02M	0.0%	-32.2%	0.095%
2/2/2023	SG Americas Securities LLC	4,339	$0.11M	0.0%	-29.6%	0.010%
12/8/2022	Bank of New York Mellon Corp	96,949	$1.74M	0.0%	+17.2%	0.223%
11/17/2022	M&T Bank Corp	27,068	$0.49M	0.0%	-18.4%	0.062%
11/16/2022	BNP Paribas Arbitrage SNC	49,318	$0.89M	0.0%	N/A	0.113%
11/15/2022	Alliancebernstein L.P.	35,200	$0.63M	0.0%	-82.1%	0.081%
11/15/2022	State Street Corp	2,040,054	$36.62M	0.0%	+282.7%	4.684%
11/15/2022	Two Sigma Advisers LP	149,800	$2.69M	0.0%	+238.9%	0.344%
11/15/2022	Two Sigma Investments LP	163,489	$2.94M	0.0%	+31.6%	0.375%
11/15/2022	Tybourne Capital Management HK Ltd.	645,815	$11.59M	1.1%	-18.7%	1.483%
11/15/2022	Vanguard Group Inc.	1,467,918	$26.35M	0.0%	+8.2%	3.371%
11/15/2022	Perceptive Advisors LLC	2,887,860	$51.84M	1.5%	+50.8%	6.631%
11/15/2022	Platinum Investment Management Ltd.	146,210	$2.62M	0.1%	-8.7%	0.336%
11/15/2022	Lido Advisors LLC	11,549	$0.21M	0.0%	-9.0%	0.027%
11/15/2022	Ensign Peak Advisors Inc	6,260	$0.11M	0.0%	+114.4%	0.014%
11/15/2022	Bank of New York Mellon Corp	96,949	$1.74M	0.0%	+17.2%	0.223%
11/15/2022	Bellevue Group AG	43,500	$0.78M	0.0%	-43.2%	0.100%
11/15/2022	Bioimpact Capital LLC	1,279,995	$22.98M	5.4%	+25.1%	2.939%
11/15/2022	BlackRock Inc.	2,190,518	$39.32M	0.0%	+10.8%	5.030%
11/14/2022	Tudor Investment Corp Et Al	20,358	$0.37M	0.0%	+7.8%	0.047%
11/14/2022	Point72 Asset Management L.P.	457,100	$8.21M	0.0%	-34.6%	1.050%
11/14/2022	Cubist Systematic Strategies LLC	76,825	$1.38M	0.0%	+27.2%	0.176%
11/14/2022	Nuveen Asset Management LLC	114,916	$2.06M	0.0%	-0.4%	0.264%
11/14/2022	UBS Oconnor LLC	71,297	$1.28M	0.0%	-16.2%	0.164%
11/10/2022	Credit Suisse AG	19,926	$0.36M	0.0%	+66.6%	0.046%
11/10/2022	Tower Research Capital LLC TRC	5,653	$0.10M	0.0%	+24.6%	0.014%
11/10/2022	UBS Group AG	17,795	$0.32M	0.0%	N/A	0.046%
11/9/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,704	$66K	0.0%	+418.0%	0.009%
11/8/2022	New York State Common Retirement Fund	20,157	$0.36M	0.0%	-7.0%	0.052%
11/7/2022	Nisa Investment Advisors LLC	2,346	$47K	0.0%	+633.1%	0.006%
11/7/2022	Jump Financial LLC	10,650	$0.19M	0.0%	-65.9%	0.027%
11/4/2022	Russell Investments Group Ltd.	340,604	$6.11M	0.0%	+34.0%	0.872%
11/3/2022	The Manufacturers Life Insurance Company	12,211	$0.22M	0.0%	-3.6%	0.031%
11/3/2022	Barclays PLC	87,078	$1.52M	0.0%	+2,711.7%	0.223%
11/2/2022	Los Angeles Capital Management LLC	61,030	$1.10M	0.0%	N/A	0.156%
11/2/2022	Victory Capital Management Inc.	76,860	$1.38M	0.0%	-13.7%	0.197%
10/31/2022	SG Americas Securities LLC	6,159	$0.11M	0.0%	N/A	0.016%
8/30/2022	Verition Fund Management LLC	95,076	$1.08M	0.0%	N/A	0.243%
8/22/2022	Legal & General Group Plc	8,383	$95K	0.0%	+52.7%	0.021%
8/22/2022	ExodusPoint Capital Management LP	67,233	$0.76M	0.0%	N/A	0.172%
8/19/2022	Walleye Capital LLC	68,138	$0.77M	0.0%	-38.4%	0.174%
8/18/2022	Goldman Sachs Group Inc.	80,447	$0.91M	0.0%	-44.3%	0.206%
8/15/2022	State Street Corp	533,068	$6.05M	0.0%	-66.6%	1.365%
8/15/2022	Point72 Hong Kong Ltd	2,879	$33K	0.0%	+154.6%	0.007%
8/15/2022	Cubist Systematic Strategies LLC	60,396	$0.69M	0.0%	+316.5%	0.155%
8/15/2022	Point72 Asset Management L.P.	699,100	$7.94M	0.0%	N/A	1.790%
8/15/2022	Opaleye Management Inc.	590,000	$6.70M	3.0%	N/A	1.511%
8/15/2022	Millennium Management LLC	947,031	$10.75M	0.0%	N/A	2.425%
8/15/2022	Sio Capital Management LLC	365,210	$4.15M	1.6%	+193.9%	0.935%
8/15/2022	UBS Asset Management Americas Inc.	10,080	$0.11M	0.0%	N/A	0.026%
8/13/2022	Quantbot Technologies LP	5,915	$67K	0.0%	+90.8%	0.015%
8/12/2022	Northern Trust Corp	260,179	$2.95M	0.0%	+2.4%	0.666%
8/12/2022	Virtus ETF Advisers LLC	12,172	$0.14M	0.1%	+206.8%	0.031%
8/12/2022	Ikarian Capital LLC	49,372	$0.56M	0.1%	-79.7%	0.126%
8/12/2022	Credit Suisse AG	11,960	$0.14M	0.0%	N/A	0.031%

Data available starting January 2016

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.

Today's Range

Now: $20.53

$20.43

$21.84

50 Day Range

MA: $23.76

$20.53

$27.14

52 Week Range

Now: $20.53

$7.67

$34.72

Volume

267,712 shs

Average Volume

417,905 shs

Market Capitalization

$894.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.96

Who are the company insiders with the largest holdings of Inhibrx?: Inhibrx's top insider shareholders include:
Jon Faiz Kayyem (Director)
Mark Lappe (CEO)
Brendan P Eckelman (Insider)
Global Investors Lp Viking (Major Shareholder)
Learn More about top insider investors at Inhibrx.
Who are the major institutional investors of Inhibrx?: Inhibrx's top institutional shareholders include:
RA Capital Management L.P. — 8.85%
ArrowMark Colorado Holdings LLC — 2.62%
Point72 Asset Management L.P. — 1.73%
Geode Capital Management LLC — 1.32%
Soleus Capital Management L.P. — 1.10%
Schroder Investment Management Group — 0.86%
Learn More about top institutional investors of Inhibrx stock.
Which major investors are selling Inhibrx stock?: Within the last quarter, INBX stock was sold by these institutional investors:
ArrowMark Colorado Holdings LLC
Schroder Investment Management Group
Millennium Management LLC
Citigroup Inc.
Victory Capital Management Inc.
Victory Capital Management Inc.
Russell Investments Group Ltd.
Los Angeles Capital Management LLC
In the last year, company insiders that have sold Inhibrx company stock include:
Jon Faiz Kayyem (Director)
Mark Lappe (CEO)
Brendan P Eckelman (Insider)
Learn More investors selling Inhibrx stock.
Which major investors are buying Inhibrx stock?: During the previous quarter, INBX stock was acquired by institutional investors including:
RA Capital Management L.P.
Point72 Asset Management L.P.
Soleus Capital Management L.P.
Morgan Stanley
Pura Vida Investments LLC
Two Sigma Investments LP
Geode Capital Management LLC
UBS Group AG

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

INBX Insider Trading

Inhibrx Insider Trading History Chart

Inhibrx Share Price & Price History

Inhibrx Insider Trading History

SEC Filings (Institutional Ownership Changes) for Inhibrx (NASDAQ:INBX)

Institutional Buying and Selling by Quarter

Inhibrx Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Inhibrx?

Who are the major institutional investors of Inhibrx?

Which major investors are selling Inhibrx stock?

Which major investors are buying Inhibrx stock?